| Literature DB >> 30609776 |
Yan Hua Zhou1, Yim Wah Mak2, Grace W K Ho3.
Abstract
There are health consequences to exposure to secondhand smoke (SHS). About two-thirds of children in China live with at least one person, usually a parent, who smokes at home. However, none of the reviews of interventions for reducing SHS have targeted children in China. The purpose of this study was to review the effectiveness of interventions for reducing parental SHS exposure at home among children in China. We searched various electronic databases for English and Chinese publications appearing between 1997 and 2017. Thirteen relevant studies were identified. Common strategies used in intervention groups were non-pharmacological approaches such as counseling plus self-help materials, and attempting to persuade fathers to quit smoking. Family interactions and follow-up sessions providing counseling or using text messages could be helpful to successful quitting. Several encouraging results were observed, including lower cotinine levels in children (n = 2), reduced tobacco consumption (n = 5), and increased quit rates (n = 6) among parents. However, the positive effects were not sustained 3~6 months after the interventions. Self-reported quitting without bio-chemical validation was the most common outcome measure. A study design using biochemical validations, a longer follow-up period, and targeting all people living with children in the same household is recommended.Entities:
Keywords: China; children; homes; parental smoking; secondhand smoke exposure
Mesh:
Substances:
Year: 2019 PMID: 30609776 PMCID: PMC6339015 DOI: 10.3390/ijerph16010107
Source DB: PubMed Journal: Int J Environ Res Public Health ISSN: 1660-4601 Impact factor: 3.390
Figure 1Flow Diagram of Included and Excluded Studies.
Quality Assessments of Studies Included in the Systematic Review (controlled intervention studies).
| Abdullah et al., 2015 [ | Yu et al., 2017 [ | Yau, 2011 [ | Chen et al., 2016 [ | Abdullah et al., 2005 [ | Chan et al., 2008 [ | Yang, 2007 [ | Li, 2000 [ | Liang & Wang, 2001 [ | |
|---|---|---|---|---|---|---|---|---|---|
| 1. Was the study described as randomized, a randomized trial, a randomized clinical trial, or an RCT? | Yes | Yes | Yes | Yes | Yes | Yes | Yes | No | No |
| 2. Was the method of randomization adequate (i.e., use of randomly generated assignment)? | Yes | Yes | Yes | Yes | Yes | Yes | Yes | NR | NR |
| 3. Was the treatment allocation concealed (so that assignments could not be predicted)? | Yes | NR | Yes | NR | Yes | Yes | NR | NR | NR |
| 4. Were the study participants and providers blinded to treatment group assignment? | NR | NR | No | NR | NR | No | NR | NR | NR |
| 5. Were the people assessing the outcomes blinded to the participants’ group assignments? | Yes | NR | Yes | NR | Yes | NR | NR | NR | NR |
| 6. Were the groups similar at baseline on important characteristics that could affect outcomes (e.g., demographics, risk factors, co-morbid conditions)? | Yes | Yes | Yes | Yes | Yes | Yes | NR | NR | NR |
| 7. Was the overall drop-out rate from the study at the endpoint 20% or lower of the number allocated to treatment? | No | Yes | No | Yes | Yes | Yes | Yes | Yes | Yes |
| 8. Was the differential drop-out rate (between treatment groups) at endpoint 15 percentage points or lower? | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes |
| 9. Was there high adherence to the intervention protocols for each treatment group? | Yes | NR | Yes | NR | NR | NR | NR | NR | NR |
| 10. Were other interventions avoided or similar in the groups (e.g., similar background treatment)? | Yes | No | Yes | Yes | Yes | NR | NR | NR | NR |
| 11. Were outcomes assessed using valid and reliable measures, implemented consistently across all study participants? | Yes | No | Yes | Yes | Yes | No | No | No | No |
| 12. Did the authors report that the sample size was sufficiently large to be able to detect a difference in the main outcome between groups with at least 80% power? | No | Yes | Yes | No | No | NR | Yes | No | No |
| 13. Were outcomes reported or subgroups analyzed pre-specified (i.e., identified before analyses were conducted)? | Yes | Yes | Yes | Yes | Yes | Yes | Yes | NR | NR |
| 14. Were all randomized participants analyzed in the group to which they were originally assigned, i.e., did they use an intention-to-treat analysis? | No | No | Yes | Yes | Yes | Yes | Yes | No | No |
| Quality rating (good, fair, or poor) | Poor | Poor | Fair | Fair | Fair | Poor | Poor | Poor | Poor |
| Additional Comments (If POOR, please state why): | the drop-out rates in both studies groups were over 40%, and no ITT analysis was done | participants who were using other services or support for smoking cessation were not excluded from the study | the dropout rates in both study groups were over 20% | all the data analysed were reported by the smokers’ spouse (i.e., non-smoking mothers) | group difference in demographic characteristics and smoking-related characteristics at baseline were not reported in this study | some important details about methodology were not reported in this study, and some participants in both groups were non-smokers | some important details about methodology were not reported in this study, the only assessment tool used in this study was developed by the authors without reliability and validity test |
CD = cannot determine; NA = not applicable; NR = not reported; ITT = intent-to-treat.
Quality Assessments of Studies Included in the Systematic Review (pre-post studies).
| Huang et al., 2016 [ | Liu et al., 2007 [ | Meng et al., 2004 [ | Huang, 2008 [ | |
|---|---|---|---|---|
| 1. Was the study question or objective clearly stated? | Yes | Yes | Yes | Yes |
| 2. Were eligibility/selection criteria for the study population pre-specified and clearly described? | Yes | No | No | Yes |
| 3. Were the participants in the study representative of those who would be eligible for the test/service/intervention in the general or clinical population of interest? | Yes | CD | No | Yes |
| 4. Were all eligible participants the met the pre-specified entry criteria enrolled? | Yes | CD | CD | Yes |
| 5. Was the sample size sufficiently large to provide confidence in the findings? | NR | NR | NR | NR |
| 6. Was the test/service/intervention clearly described and delivered consistently across the study population? | Yes | Yes | Yes | Yes |
| 7. Were the outcome measures pre-specified, clearly defined, valid, reliable, and assessed consistently across all study participants? | Yes | Yes | No | Yes |
| 8. Were the people assessing the outcomes blinded to the participants’ exposure/ interventions? | Yes | NR | NR | NR |
| 9. Was the loss to follow-up after baseline 20% or less? Were those lost to follow-up accounted for in the analysis? | No | No | No | Yes |
| 10. Did the statistical methods examine changes in outcome measures from before to after the intervention? Were statistical tests done that provided | Yes | No | No | Yes |
| 11. Were outcome measures of interest taken multiple times before the intervention and multiple times after the intervention? (i.e., did they use an interrupted time-series design) | No | No | No | No |
| 12. If the intervention was conducted at a group level (e.g., a whole hospital, a community, etc.) did the statistical analysis take into account the use of individual-level data to determine effects at the group levels? | NA | NA | NA | NA |
| Quality rating (good, fair, or poor) | Fair | Poor | Poor | Fair |
| Additional Comments (If POOR, please state why): | some important details about methodology were not reported in this study, which makes the results unreliable | some important details about methodology were not reported in this study, which makes the results unreliable |
CD = cannot determine; NA = not applicable; NR = not reported.